Acinar adenocarcinoma
Acinar adenocarcinoma is a type of cancer that originates from the acinar cells of the exocrine glands. These glands are responsible for producing and secreting substances such as saliva, sweat, and digestive enzymes. Acinar adenocarcinoma is most commonly found in the pancreas, but can also occur in other organs such as the salivary glands, lungs, and prostate.
Etiology[edit]
The exact cause of acinar adenocarcinoma is not known. However, several risk factors have been identified, including smoking, chronic pancreatitis, and certain genetic conditions such as hereditary pancreatitis and Peutz-Jeghers syndrome.
Pathophysiology[edit]
Acinar adenocarcinoma develops when the DNA of acinar cells becomes damaged or altered. These genetic changes can cause the cells to grow and divide uncontrollably, leading to the formation of a tumor. Over time, the tumor can invade nearby tissues and spread to other parts of the body through the lymphatic system or bloodstream.
Clinical Presentation[edit]
The symptoms of acinar adenocarcinoma can vary depending on the location of the tumor. Common symptoms include abdominal pain, jaundice, weight loss, and digestive problems. If the tumor is located in the pancreas, it may also cause diabetes.
Diagnosis[edit]
Diagnosis of acinar adenocarcinoma typically involves a combination of physical examination, imaging tests such as computed tomography (CT) scans and magnetic resonance imaging (MRI), and biopsy. The definitive diagnosis is usually made by examining a sample of the tumor under a microscope.
Treatment[edit]
Treatment for acinar adenocarcinoma depends on the stage of the disease, the patient's overall health, and the location of the tumor. Options may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.
Prognosis[edit]
The prognosis for acinar adenocarcinoma varies widely depending on the stage of the disease at diagnosis, the patient's overall health, and the effectiveness of treatment. Early detection and treatment can significantly improve the prognosis.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
